TP53 and ovarian carcinoma: Furthermore, expressions of CHK1 and p53 were inhibited by shRNA plasmids transfection respectively, which aimed to analyze the possible molecular mechanism of CDK1 functions in proliferation and apoptosis of ovarian cancer.